Economic burden of cancer in Korea during 2000-2010

Kwang Sig Lee, Hoo Sun Chang, Sun Mi Lee, Eun Cheol Park

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods: Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results: With an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion: Incorporation of distinctive epidemiological, sociocultural contexts into Korea's cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.

Original languageEnglish
Pages (from-to)387-398
Number of pages12
JournalCancer Research and Treatment
Volume47
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Korea
Economics
Neoplasms
Thyroid Neoplasms
Costs and Cost Analysis
Colorectal Neoplasms
Age Groups
Breast Neoplasms
Cost of Illness
Mortality
National Health Programs
Primary Prevention
Liver Neoplasms
Hepatitis B
Stomach Neoplasms
Prostatic Neoplasms
Vaccination
Sodium
Diet
Morbidity

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Lee, Kwang Sig ; Chang, Hoo Sun ; Lee, Sun Mi ; Park, Eun Cheol. / Economic burden of cancer in Korea during 2000-2010. In: Cancer Research and Treatment. 2015 ; Vol. 47, No. 3. pp. 387-398.
@article{5f465f1dcb344bd58f2b47281e984592,
title = "Economic burden of cancer in Korea during 2000-2010",
abstract = "Purpose: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods: Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results: With an average annual growth rate of 8.9{\%}, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71{\%} to 51{\%} in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion: Incorporation of distinctive epidemiological, sociocultural contexts into Korea's cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.",
author = "Lee, {Kwang Sig} and Chang, {Hoo Sun} and Lee, {Sun Mi} and Park, {Eun Cheol}",
year = "2015",
month = "1",
day = "1",
doi = "10.4143/crt.2014.001",
language = "English",
volume = "47",
pages = "387--398",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Cancer Association",
number = "3",

}

Economic burden of cancer in Korea during 2000-2010. / Lee, Kwang Sig; Chang, Hoo Sun; Lee, Sun Mi; Park, Eun Cheol.

In: Cancer Research and Treatment, Vol. 47, No. 3, 01.01.2015, p. 387-398.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Economic burden of cancer in Korea during 2000-2010

AU - Lee, Kwang Sig

AU - Chang, Hoo Sun

AU - Lee, Sun Mi

AU - Park, Eun Cheol

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods: Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results: With an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion: Incorporation of distinctive epidemiological, sociocultural contexts into Korea's cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.

AB - Purpose: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods: Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results: With an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion: Incorporation of distinctive epidemiological, sociocultural contexts into Korea's cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.

UR - http://www.scopus.com/inward/record.url?scp=84937147747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937147747&partnerID=8YFLogxK

U2 - 10.4143/crt.2014.001

DO - 10.4143/crt.2014.001

M3 - Article

AN - SCOPUS:84937147747

VL - 47

SP - 387

EP - 398

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 3

ER -